BR102020020276A2 - Supplement for physical and mental recovery and kit comprising supplement - Google Patents
Supplement for physical and mental recovery and kit comprising supplement Download PDFInfo
- Publication number
- BR102020020276A2 BR102020020276A2 BR102020020276-6A BR102020020276A BR102020020276A2 BR 102020020276 A2 BR102020020276 A2 BR 102020020276A2 BR 102020020276 A BR102020020276 A BR 102020020276A BR 102020020276 A2 BR102020020276 A2 BR 102020020276A2
- Authority
- BR
- Brazil
- Prior art keywords
- supplement
- bisglycinate
- acid
- calcium
- cysteine
- Prior art date
Links
- 239000013589 supplement Substances 0.000 title claims abstract description 23
- 238000011084 recovery Methods 0.000 title claims abstract description 10
- 230000003340 mental effect Effects 0.000 title claims abstract description 9
- 239000000203 mixture Substances 0.000 claims abstract description 21
- 235000001014 amino acid Nutrition 0.000 claims abstract description 10
- 150000001413 amino acids Chemical class 0.000 claims abstract description 10
- 229910052500 inorganic mineral Inorganic materials 0.000 claims abstract description 10
- 239000011707 mineral Substances 0.000 claims abstract description 10
- 235000010755 mineral Nutrition 0.000 claims abstract description 9
- 229940088594 vitamin Drugs 0.000 claims abstract description 9
- 229930003231 vitamin Natural products 0.000 claims abstract description 9
- 235000013343 vitamin Nutrition 0.000 claims abstract description 9
- 239000011782 vitamin Substances 0.000 claims abstract description 9
- 235000014113 dietary fatty acids Nutrition 0.000 claims abstract description 7
- 239000000194 fatty acid Substances 0.000 claims abstract description 7
- 229930195729 fatty acid Natural products 0.000 claims abstract description 7
- 150000004665 fatty acids Chemical class 0.000 claims abstract description 7
- 235000015872 dietary supplement Nutrition 0.000 claims abstract description 6
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 claims description 18
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims description 11
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 10
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 10
- 239000002775 capsule Substances 0.000 claims description 10
- RMRCNWBMXRMIRW-BYFNXCQMSA-M cyanocobalamin Chemical compound N#C[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O RMRCNWBMXRMIRW-BYFNXCQMSA-M 0.000 claims description 10
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims description 10
- AGBQKNBQESQNJD-UHFFFAOYSA-N lipoic acid Chemical compound OC(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-N 0.000 claims description 8
- PWKSKIMOESPYIA-BYPYZUCNSA-N L-N-acetyl-Cysteine Chemical compound CC(=O)N[C@@H](CS)C(O)=O PWKSKIMOESPYIA-BYPYZUCNSA-N 0.000 claims description 7
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 6
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 6
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims description 6
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 claims description 6
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims description 6
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 claims description 6
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 claims description 6
- 235000013734 beta-carotene Nutrition 0.000 claims description 6
- 239000011648 beta-carotene Substances 0.000 claims description 6
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 claims description 6
- 229960002747 betacarotene Drugs 0.000 claims description 6
- 239000011575 calcium Substances 0.000 claims description 6
- 229910052791 calcium Inorganic materials 0.000 claims description 6
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 claims description 6
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 claims description 6
- 235000018417 cysteine Nutrition 0.000 claims description 6
- 239000004615 ingredient Substances 0.000 claims description 6
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 claims description 6
- 229960002477 riboflavin Drugs 0.000 claims description 6
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 claims description 6
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 claims description 6
- ZNOVTXRBGFNYRX-STQMWFEESA-N (6S)-5-methyltetrahydrofolic acid Chemical compound C([C@@H]1N(C=2C(=O)N=C(N)NC=2NC1)C)NC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 ZNOVTXRBGFNYRX-STQMWFEESA-N 0.000 claims description 5
- JNMKPXXKHWQWFB-UHFFFAOYSA-L 2-aminoacetate;manganese(2+) Chemical compound [Mn+2].NCC([O-])=O.NCC([O-])=O JNMKPXXKHWQWFB-UHFFFAOYSA-L 0.000 claims description 5
- 235000016425 Arthrospira platensis Nutrition 0.000 claims description 5
- 240000002900 Arthrospira platensis Species 0.000 claims description 5
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 claims description 5
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 claims description 5
- 239000004471 Glycine Substances 0.000 claims description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 5
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims description 5
- CXJDAFVDDRIBOH-UHFFFAOYSA-J [Mg++].[Mg++].OC(CC([O-])=O)C([O-])=O.OC(CC([O-])=O)C([O-])=O Chemical compound [Mg++].[Mg++].OC(CC([O-])=O)C([O-])=O.OC(CC([O-])=O)C([O-])=O CXJDAFVDDRIBOH-UHFFFAOYSA-J 0.000 claims description 5
- OLOZVPHKXALCRI-UHFFFAOYSA-L calcium malate Chemical compound [Ca+2].[O-]C(=O)C(O)CC([O-])=O OLOZVPHKXALCRI-UHFFFAOYSA-L 0.000 claims description 5
- 239000001362 calcium malate Substances 0.000 claims description 5
- 229940016114 calcium malate Drugs 0.000 claims description 5
- 235000011038 calcium malates Nutrition 0.000 claims description 5
- 229960002079 calcium pantothenate Drugs 0.000 claims description 5
- 229960004874 choline bitartrate Drugs 0.000 claims description 5
- QWJSAWXRUVVRLH-UHFFFAOYSA-M choline bitartrate Chemical compound C[N+](C)(C)CCO.OC(=O)C(O)C(O)C([O-])=O QWJSAWXRUVVRLH-UHFFFAOYSA-M 0.000 claims description 5
- 229960002104 cyanocobalamin Drugs 0.000 claims description 5
- 235000000639 cyanocobalamin Nutrition 0.000 claims description 5
- 239000011666 cyanocobalamin Substances 0.000 claims description 5
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 claims description 5
- 235000013922 glutamic acid Nutrition 0.000 claims description 5
- 239000004220 glutamic acid Substances 0.000 claims description 5
- 229960003208 levomefolic acid Drugs 0.000 claims description 5
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 claims description 5
- 239000001508 potassium citrate Substances 0.000 claims description 5
- 229960002635 potassium citrate Drugs 0.000 claims description 5
- QEEAPRPFLLJWCF-UHFFFAOYSA-K potassium citrate (anhydrous) Chemical compound [K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QEEAPRPFLLJWCF-UHFFFAOYSA-K 0.000 claims description 5
- 235000011082 potassium citrates Nutrition 0.000 claims description 5
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 claims description 5
- 239000011764 pyridoxine hydrochloride Substances 0.000 claims description 5
- 229960004172 pyridoxine hydrochloride Drugs 0.000 claims description 5
- 235000019192 riboflavin Nutrition 0.000 claims description 5
- 239000002151 riboflavin Substances 0.000 claims description 5
- 239000011780 sodium chloride Substances 0.000 claims description 5
- 229940082787 spirulina Drugs 0.000 claims description 5
- 229960003080 taurine Drugs 0.000 claims description 5
- 229940042585 tocopherol acetate Drugs 0.000 claims description 5
- UOXSXMSTSYWNMH-UHFFFAOYSA-L zinc;2-aminoacetate Chemical compound [Zn+2].NCC([O-])=O.NCC([O-])=O UOXSXMSTSYWNMH-UHFFFAOYSA-L 0.000 claims description 5
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims description 4
- 235000003704 aspartic acid Nutrition 0.000 claims description 4
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 claims description 4
- 235000019136 lipoic acid Nutrition 0.000 claims description 4
- 229960004839 potassium iodide Drugs 0.000 claims description 4
- 229960002663 thioctic acid Drugs 0.000 claims description 4
- ONNUGJZRNAYWNS-UHFFFAOYSA-N NCC(O)=O.NCC(O)=O.[SeH2] Chemical compound NCC(O)=O.NCC(O)=O.[SeH2] ONNUGJZRNAYWNS-UHFFFAOYSA-N 0.000 claims description 3
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims description 3
- 229940097761 ascorbic acid 125 mg Drugs 0.000 claims description 3
- 229940019897 coenzyme Q10 30 mg Drugs 0.000 claims description 3
- 229940000065 linoleic acid 10 mg Drugs 0.000 claims description 3
- 229940100419 phosphatidylserine 50 mg Drugs 0.000 claims description 3
- 150000003839 salts Chemical class 0.000 claims description 3
- 239000011669 selenium Substances 0.000 claims description 3
- 229910052711 selenium Inorganic materials 0.000 claims description 3
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 claims description 2
- TZCPCKNHXULUIY-RGULYWFUSA-N 1,2-distearoyl-sn-glycero-3-phosphoserine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OC[C@H](N)C(O)=O)OC(=O)CCCCCCCCCCCCCCCCC TZCPCKNHXULUIY-RGULYWFUSA-N 0.000 claims description 2
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 claims description 2
- ZWZWYGMENQVNFU-UHFFFAOYSA-N Glycerophosphorylserin Natural products OC(=O)C(N)COP(O)(=O)OCC(O)CO ZWZWYGMENQVNFU-UHFFFAOYSA-N 0.000 claims description 2
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 claims description 2
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims description 2
- 229960005070 ascorbic acid Drugs 0.000 claims description 2
- 235000010323 ascorbic acid Nutrition 0.000 claims description 2
- 239000011668 ascorbic acid Substances 0.000 claims description 2
- 235000017471 coenzyme Q10 Nutrition 0.000 claims description 2
- 229940110767 coenzyme Q10 Drugs 0.000 claims description 2
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 claims description 2
- 239000007937 lozenge Substances 0.000 claims description 2
- 235000007715 potassium iodide Nutrition 0.000 claims description 2
- 229960002668 sodium chloride Drugs 0.000 claims description 2
- 235000002639 sodium chloride Nutrition 0.000 claims description 2
- 239000003826 tablet Substances 0.000 claims description 2
- PWKSKIMOESPYIA-UHFFFAOYSA-N 2-acetamido-3-sulfanylpropanoic acid Chemical compound CC(=O)NC(CS)C(O)=O PWKSKIMOESPYIA-UHFFFAOYSA-N 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 239000006187 pill Substances 0.000 claims 1
- SHXWCVYOXRDMCX-UHFFFAOYSA-N 3,4-methylenedioxymethamphetamine Chemical compound CNC(C)CC1=CC=C2OCOC2=C1 SHXWCVYOXRDMCX-UHFFFAOYSA-N 0.000 description 13
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 description 10
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 8
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 8
- 230000003078 antioxidant effect Effects 0.000 description 8
- 239000003963 antioxidant agent Substances 0.000 description 7
- 235000006708 antioxidants Nutrition 0.000 description 7
- 230000006870 function Effects 0.000 description 7
- 235000015097 nutrients Nutrition 0.000 description 7
- 230000015572 biosynthetic process Effects 0.000 description 6
- 230000037149 energy metabolism Effects 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- 230000002232 neuromuscular Effects 0.000 description 6
- 150000003254 radicals Chemical class 0.000 description 6
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 5
- 229940076279 serotonin Drugs 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- 108010010803 Gelatin Proteins 0.000 description 4
- 208000000112 Myalgia Diseases 0.000 description 4
- 229930003427 Vitamin E Natural products 0.000 description 4
- 230000009471 action Effects 0.000 description 4
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 206010016256 fatigue Diseases 0.000 description 4
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 4
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 4
- 229920000159 gelatin Polymers 0.000 description 4
- 239000008273 gelatin Substances 0.000 description 4
- 235000019322 gelatine Nutrition 0.000 description 4
- 235000011852 gelatine desserts Nutrition 0.000 description 4
- 239000003349 gelling agent Substances 0.000 description 4
- 210000000987 immune system Anatomy 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 238000012423 maintenance Methods 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 239000004408 titanium dioxide Substances 0.000 description 4
- 235000019165 vitamin E Nutrition 0.000 description 4
- 229940046009 vitamin E Drugs 0.000 description 4
- 239000011709 vitamin E Substances 0.000 description 4
- 108010024636 Glutathione Proteins 0.000 description 3
- 206010029350 Neurotoxicity Diseases 0.000 description 3
- 206010044221 Toxic encephalopathy Diseases 0.000 description 3
- 229960004308 acetylcysteine Drugs 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 230000008030 elimination Effects 0.000 description 3
- 238000003379 elimination reaction Methods 0.000 description 3
- 235000019152 folic acid Nutrition 0.000 description 3
- 239000011724 folic acid Substances 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 210000000653 nervous system Anatomy 0.000 description 3
- 230000003955 neuronal function Effects 0.000 description 3
- 231100000228 neurotoxicity Toxicity 0.000 description 3
- 230000007135 neurotoxicity Effects 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 208000016255 tiredness Diseases 0.000 description 3
- 230000003867 tiredness Effects 0.000 description 3
- 239000003053 toxin Substances 0.000 description 3
- 231100000765 toxin Toxicity 0.000 description 3
- 108700012359 toxins Proteins 0.000 description 3
- 230000036642 wellbeing Effects 0.000 description 3
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 2
- FFFHZYDWPBMWHY-VKHMYHEASA-N L-homocysteine Chemical compound OC(=O)[C@@H](N)CCS FFFHZYDWPBMWHY-VKHMYHEASA-N 0.000 description 2
- 206010044565 Tremor Diseases 0.000 description 2
- 206010047631 Vitamin E deficiency Diseases 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 229960001948 caffeine Drugs 0.000 description 2
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 230000006735 deficit Effects 0.000 description 2
- 238000001784 detoxification Methods 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 235000021321 essential mineral Nutrition 0.000 description 2
- 229940014144 folate Drugs 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 229960003180 glutathione Drugs 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000007866 hepatic necrosis Effects 0.000 description 2
- 206010019692 hepatic necrosis Diseases 0.000 description 2
- 230000036571 hydration Effects 0.000 description 2
- 238000006703 hydration reaction Methods 0.000 description 2
- 235000011090 malic acid Nutrition 0.000 description 2
- 239000001630 malic acid Substances 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 230000036651 mood Effects 0.000 description 2
- 208000013465 muscle pain Diseases 0.000 description 2
- 231100000189 neurotoxic Toxicity 0.000 description 2
- 230000002887 neurotoxic effect Effects 0.000 description 2
- 239000002858 neurotransmitter agent Substances 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 230000002441 reversible effect Effects 0.000 description 2
- 230000007958 sleep Effects 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- JWDYCNIAQWPBHD-UHFFFAOYSA-N 1-(2-methylphenyl)glycerol Chemical compound CC1=CC=CC=C1OCC(O)CO JWDYCNIAQWPBHD-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 208000027796 Blood pressure disease Diseases 0.000 description 1
- SGHZXLIDFTYFHQ-UHFFFAOYSA-L Brilliant Blue Chemical compound [Na+].[Na+].C=1C=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C(=CC=CC=2)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=CC(S([O-])(=O)=O)=C1 SGHZXLIDFTYFHQ-UHFFFAOYSA-L 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 208000028698 Cognitive impairment Diseases 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- YVGGHNCTFXOJCH-UHFFFAOYSA-N DDT Chemical compound C1=CC(Cl)=CC=C1C(C(Cl)(Cl)Cl)C1=CC=C(Cl)C=C1 YVGGHNCTFXOJCH-UHFFFAOYSA-N 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- 206010054089 Depressive symptom Diseases 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010019133 Hangover Diseases 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 208000010428 Muscle Weakness Diseases 0.000 description 1
- 206010049565 Muscle fatigue Diseases 0.000 description 1
- 206010028372 Muscular weakness Diseases 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 241001614207 Pamplona Species 0.000 description 1
- 208000028017 Psychotic disease Diseases 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- LXNHXLLTXMVWPM-UHFFFAOYSA-N Vitamin B6 Natural products CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 206010048259 Zinc deficiency Diseases 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 230000006851 antioxidant defense Effects 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000005013 brain tissue Anatomy 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000032677 cell aging Effects 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000037326 chronic stress Effects 0.000 description 1
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 1
- 208000010877 cognitive disease Diseases 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- LQJVOKWHGUAUHK-UHFFFAOYSA-L disodium 5-amino-4-hydroxy-3-phenyldiazenylnaphthalene-2,7-disulfonate Chemical compound [Na+].[Na+].OC1=C2C(N)=CC(S([O-])(=O)=O)=CC2=CC(S([O-])(=O)=O)=C1N=NC1=CC=CC=C1 LQJVOKWHGUAUHK-UHFFFAOYSA-L 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 229960003638 dopamine Drugs 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000004626 essential fatty acids Nutrition 0.000 description 1
- 235000020774 essential nutrients Nutrition 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 230000009688 glial response Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000007407 health benefit Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000010438 iron metabolism Effects 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- JFQQIWNDAXACSR-UHFFFAOYSA-L magnesium malate Chemical compound [Mg+2].[O-]C(=O)C(O)CC([O-])=O JFQQIWNDAXACSR-UHFFFAOYSA-L 0.000 description 1
- 229940096424 magnesium malate Drugs 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 239000011572 manganese Substances 0.000 description 1
- 230000007334 memory performance Effects 0.000 description 1
- 230000002438 mitochondrial effect Effects 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 208000015122 neurodegenerative disease Diseases 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 230000011164 ossification Effects 0.000 description 1
- 230000004792 oxidative damage Effects 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 230000003405 preventing effect Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 230000000862 serotonergic effect Effects 0.000 description 1
- 230000003860 sleep quality Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
Abstract
A presente invenção refere-se a um suplemento para recuperação física e mental compreendendo uma combinação de pelo menos 30 componentes escolhidos dentre amino ácidos, vitaminas, minerais, ácidos graxos e suplementos dietéticos. Preferencialmente a combinação é dividida em pelo menos 4 composições diferentes para ser administrada por via oral.The present invention relates to a supplement for physical and mental recovery comprising a combination of at least 30 components chosen from amino acids, vitamins, minerals, fatty acids and dietary supplements. Preferably the combination is divided into at least 4 different compositions to be administered orally.
Description
[001] A presente invenção refere-se a um suplemento para recuperação física e mental compreendendo uma combinação de pelo menos 30 componentes escolhidos dentre amino ácidos, vitaminas, minerais, ácidos graxos e suplementos dietéticos. Preferencialmente a combinação é dividida em pelo menos 4 composições diferentes para ser administrada por via oral.[001] The present invention relates to a supplement for physical and mental recovery comprising a combination of at least 30 components chosen from amino acids, vitamins, minerals, fatty acids and dietary supplements. Preferably the combination is divided into at least 4 different compositions to be administered orally.
[002] A presente invenção é destinada a indivíduos que sofreram o esgotamento dos nutrientes corporais, resultando em sintomas indesejados no dia seguinte, como resultado de atividades prolongadas e extenuantes, como por exemplo participação de festivais.[002] The present invention is intended for individuals who have experienced depletion of body nutrients, resulting in unwanted symptoms the next day, as a result of prolonged and strenuous activities, such as attending festivals.
[003] É comum o uso de substâncias tóxicas em festivais de música eletrônica, o que causa o desequilíbrio de diversas funções do organismo e o esgotamento de nutrientes e minerais essenciais e seus efeitos colaterais são sentidos no dia seguinte, com sintomas como fadiga, dores musculares, tristeza profunda, raciocínio lento e tremores.[003] It is common to use toxic substances in electronic music festivals, which causes the imbalance of various body functions and the depletion of essential nutrients and minerals and their side effects are felt the next day, with symptoms such as fatigue, pain muscles, deep sadness, slow thinking and tremors.
[004] Após os festivais, é possível notar sintomas como mal-estar, dores musculares, cansaço, fadiga, tristeza profunda e raciocínio lento. Em pesquisa, foi constatado que tais sintomas resultavam do esgotamento de nutrientes e minerais. Atualmente existem produtos similares no mercado, estando alguns deles detalhados a seguir:[004] After the festivals, it is possible to notice symptoms such as malaise, muscle aches, tiredness, fatigue, deep sadness and slow thinking. In research, it was found that such symptoms resulted from the depletion of nutrients and minerals. There are currently similar products on the market, some of which are detailed below:
[005] ENGOV After é um produto composto apenas por glicose, sais minerais e cafeína, que visa reequilibrar a hidratação do organismo e promover mais energia através da cafeína. Sua composição extremamente simples resolve apenas 1 dos diversos sintomas da ressaca.[005] ENGOV After is a product composed only of glucose, mineral salts and caffeine, which aims to rebalance the body's hydration and promote more energy through caffeine. Its extremely simple composition resolves just 1 of the many hangover symptoms.
[006] Outros exemplos de produtos similares incluem ENGOV, Epocler e Xantinon. Entretanto, nenhum desses produtos proporciona uma recuperação física e mental adequada do indivíduo.[006] Other examples of similar products include ENGOV, Epocler and Xantinon. However, none of these products provide an adequate physical and mental recovery of the individual.
[007] Portanto há uma necessidade de composições para recuperação física e mental que possua quantidades suficientes para promover o efeito desejado ao indivíduo.[007] Therefore there is a need for compositions for physical and mental recovery that have sufficient amounts to promote the desired effect to the individual.
[008] O objetivo da presente invenção é reduzir os danos do consumo de substâncias tóxicas, recuperando rapidamente o organismo enquanto a pessoa dorme após os festivais de música, onde geralmente ocorre o consumo, reestabelecendo os níveis ideais dos nutrientes para o funcionamento adequado do organismo.[008] The objective of the present invention is to reduce the damage caused by the consumption of toxic substances, quickly recovering the body while the person sleeps after music festivals, where consumption usually occurs, reestablishing the ideal levels of nutrients for the proper functioning of the body. .
[009] É um objeto da presente invenção um suplemento para recuperação física e mental compreendendo pelo menos 30 ingredientes selecionados dentre: aminoácidos, vitaminas, minerais, ácidos graxos e suplementos dietéticos.[009] It is an object of the present invention a supplement for physical and mental recovery comprising at least 30 ingredients selected from: amino acids, vitamins, minerals, fatty acids and dietary supplements.
[0010] Em uma realização preferencial, os aminoácidos são selecionados dentre aminoácidos essenciais e não-essenciais, as vitaminas são vitaminas lipofílicas e hidrofílicas, os ácidos graxos são ácidos graxos essenciais.[0010] In a preferred embodiment, the amino acids are selected from essential and non-essential amino acids, the vitamins are lipophilic and hydrophilic vitamins, the fatty acids are essential fatty acids.
[0011] É um adicional objeto da presente invenção um kit compreendendo a composição do suplemento para recuperação física e mental.[0011] It is a further object of the present invention a kit comprising the composition of the supplement for physical and mental recovery.
[0012] Preferencialmente, o kit compreende quatro composições distintas que juntas correspondem ao suplemento para recuperação física e mental.[0012] Preferably, the kit comprises four distinct compositions which together correspond to the supplement for physical and mental recovery.
[0013] Essas e outras vantagens ficarão mais claras a partir da descrição detalhada abaixo.[0013] These and other advantages will become clearer from the detailed description below.
[0014] A descrição a seguir tem o intuito somente de exemplificar algumas das inúmeras formas de se realizar a invenção, e não deve ser encarada de modo a limitar o escopo da presente invenção.[0014] The description below is intended only to exemplify some of the numerous ways of carrying out the invention, and should not be viewed as limiting the scope of the present invention.
[0015] O suplemento da presente invenção compreende os seguintes ingredientes:[0015] The supplement of the present invention comprises the following ingredients:
[0016] Aminoácidos: taurina, cisteína, N-acetil L-cisteína, glicina, ácido aspártico, ácido glutâmico, triptofano, tirosina, fenilalanina.[0016] Amino acids: taurine, cysteine, N-acetyl L-cysteine, glycine, aspartic acid, glutamic acid, tryptophan, tyrosine, phenylalanine.
[0017] Vitaminas: beta caroteno, ácido ascórbico, vitamina E acetato, bitartarato de colina, pantotenato de cálcio, cianocobalamina, riboflavina cloridrato, piridoxina cloridrato, metil folato de cálcio.[0017] Vitamins: beta carotene, ascorbic acid, vitamin E acetate, choline bitartrate, calcium pantothenate, cyanocobalamin, riboflavin hydrochloride, pyridoxine hydrochloride, calcium methyl folate.
[0018] Sais minerais: selênio bisglicinato, cloreto de sódio, citrato de potássio, iodeto de potássio, cálcio malato, magnésio dimalato, manganês bisglicinato, zinco bisglicinato.[0018] Mineral salts: selenium bisglycinate, sodium chloride, potassium citrate, potassium iodide, calcium malate, magnesium dimalate, manganese bisglycinate, zinc bisglycinate.
[0019] Ácidos graxos: ácido alfa-lipóico, ácido linoleico, fosfatidilserina.[0019] Fatty acids: alpha-lipoic acid, linoleic acid, phosphatidylserine.
[0020] Suplementos dietéticos: Espirulina, coenzima Q10.[0020] Dietary Supplements: Spirulina, Coenzyme Q10.
[0021] Os benefícios de alguns dos ingredientes da presente invenção são listados abaixo:[0021] The benefits of some of the ingredients of the present invention are listed below:
[0022] Em um estudo realizado pelo Departamento de Farmacologia da Faculdade de Medicina da Universidade de Navarra em Pamplona na Espanha, foi constatado que a administração de ácido alfa-lipóico em ratos evitou completamente os déficits serotoninérgicos (déficit de serotonina pós uso de MDMA por utilizar de forma indevida as reservas do organismo) e as alterações na resposta glial (liberação indevida de neurotransmissores) induzidas pelo MDMA. Esses resultados apoiam ainda mais a hipótese de que a formação de radicais livres é responsável pela neurotoxicidade induzida por MDMA.[0022] In a study carried out by the Department of Pharmacology of the Faculty of Medicine of the University of Navarra in Pamplona in Spain, it was found that the administration of alpha-lipoic acid in rats completely avoided serotonergic deficits (serotonin deficit after the use of MDMA by misuse of the body's reserves) and changes in the glial response (improper release of neurotransmitters) induced by MDMA. These results further support the hypothesis that free radical formation is responsible for MDMA-induced neurotoxicity.
[0023] No Brasil, a utilização do ácido alfa-lipóico em suplementos não é liberada pela ANVISA. Por isso, pode-se usar o ácido linoleico que apresenta função equivalente na desintoxicação pós utilização de MDMA, somados a outros componentes presentes na fórmula DETOX que possuem ação contra a ação dos radicais livres.[0023] In Brazil, the use of alpha-lipoic acid in supplements is not authorized by ANVISA. Therefore, linoleic acid can be used, which has an equivalent function in post-use MDMA detoxification, in addition to other components present in the DETOX formula that have action against the action of free radicals.
[0024] Um estudo realizado pelo Serviço de Toxicologia da Faculdade de Farmácia da Universidade do Porto em Portugal forneceu evidências de que a N Acetil Cisteína (NAC) impediu a depleção de glutationa induzida pelo uso de MDMA. Uma vez que os sistemas de defesa antioxidante são prejudicados pelo consumo dessa substância, a administração de NAC evitou a toxicidade hepática do MDMA.[0024] A study carried out by the Toxicology Service of the Faculty of Pharmacy of the University of Porto in Portugal provided evidence that N Acetyl Cysteine (NAC) prevented MDMA-induced glutathione depletion. Since the antioxidant defense systems are impaired by the consumption of this substance, the administration of NAC avoided the hepatic toxicity of MDMA.
[0025] Um estudo realizado pelo Laboratório de Estresse Crônico do Instituto Nacional de Segurança e Saúde Ocupacional e Centros de Controle de Doenças de Morgantown nos Estados Unidos, analisou os efeitos na neurotoxicidade do uso de MDMA em organismos com deficiência de vitamina E. No cérebro, o tratamento com MDMA reduziu a vitamina E e a reserva antioxidante total. No fígado, o tratamento com MDMA reduziu a glutationa e a reserva antioxidante total no mesmo momento. O grupo com deficiência de vitamina E, tratado com a dose de MDMA, exibiu respostas neurotóxicas enquanto o grupo da dieta suficiente em vitamina E não foi alterado. A dose mais alta de d-MDMA causou respostas neurotóxicas nos dois grupos de dieta. O MDMA causou necrose hepática mais severa em vitamina E deficiente do que camundongos suficientes. Estes dados indicam que (1) a administração de d-MDMA reduz as medidas antioxidantes com o uso do MDMA e (2) a deficiência de vitamina E aumenta a suscetibilidade à neurotoxicidade e necrose hepática induzidas por MDMA.[0025] A study conducted by the Chronic Stress Laboratory of the National Institute for Occupational Safety and Health and the Morgantown Centers for Disease Control in the United States analyzed the effects on neurotoxicity of the use of MDMA in organisms with vitamin E deficiency. In the brain , MDMA treatment reduced vitamin E and total antioxidant reserve. In the liver, MDMA treatment reduced glutathione and total antioxidant reserve at the same time. The vitamin E deficient group treated with the MDMA dose exhibited neurotoxic responses while the vitamin E sufficient diet group was not altered. The higher dose of d-MDMA caused neurotoxic responses in both diet groups. MDMA caused more severe hepatic necrosis in vitamin E deficient than enough mice. These data indicate that (1) d-MDMA administration reduces antioxidant measures with MDMA use and (2) vitamin E deficiency increases susceptibility to MDMA-induced neurotoxicity and hepatic necrosis.
[0026] A vitamina C atua como um forte antioxidante, combatendo os radicais livres que causam envelhecimento celular e doenças degenerativas. Esse nutriente tem sido associado a outros benefícios à saúde, incluindo redução da pressão arterial e de risco de doenças cardíacas, melhora na absorção de ferro, aumento da imunidade e redução do risco de demência.[0026] Vitamin C acts as a strong antioxidant, fighting free radicals that cause cellular aging and degenerative diseases. This nutrient has been linked to other health benefits, including lowering blood pressure and heart disease risk, improving iron absorption, boosting immunity, and reducing the risk of dementia.
[0027] A vitamina B2 atua como um importante antioxidante no organismo. A ingestão de B2 auxilia a proteção de DNA, proteínas e lipídios contra danos oxidativos.[0027] Vitamin B2 acts as an important antioxidant in the body. Intake of B2 helps protect DNA, proteins and lipids from oxidative damage.
[0028] O zinco está envolvido em mais de 300 reações enzimáticas no corpo. Níveis adequados de zinco são essenciais para o humor estável. Estudos recentes relataram que a deficiência de zinco é vista na depressão e na psicose. Além disso, exerce função antioxidante que auxilia na proteção contra os danos causados pelos radicais livres.[0028] Zinc is involved in over 300 enzymatic reactions in the body. Adequate zinc levels are essential for a stable mood. Recent studies have reported that zinc deficiency is seen in depression and psychosis. In addition, it exerts an antioxidant function that helps protect against damage caused by free radicals.
[0029] O selênio atua como um importante antioxidante que protege o organismo contra a ação dos radicais livres e auxilia no funcionamento do sistema imunológico.[0029] Selenium acts as an important antioxidant that protects the body against the action of free radicals and assists in the functioning of the immune system.
[0030] O manganês é um mineral fundamental para vários processos fisiológicos importantes, incluindo ação antioxidante contra os danos causados pelos radicais livres, metabolismo energético, manutenção dos tecidos conectivos e na formação de ossos. É essencial para saúde mitocondrial, bem como para o funcionamento ideal das enzimas essenciais a todas as células e neurônios.[0030] Manganese is a fundamental mineral for several important physiological processes, including antioxidant action against free radical damage, energy metabolism, maintenance of connective tissues and bone formation. It is essential for mitochondrial health, as well as for the optimal functioning of enzymes essential to all cells and neurons.
[0031] O beta caroteno é um nutriente percursor da vitamina A, que auxilia o bom funcionamento do sistema imune, da visão e colabora com a manutenção das mucosas e da pele. Além disso, contribui com o metabolismo do ferro e do processo de diferenciação celular.[0031] Beta carotene is a precursor nutrient of vitamin A, which helps the proper functioning of the immune system, vision and collaborates with the maintenance of mucous membranes and skin. In addition, it contributes to iron metabolism and the process of cell differentiation.
[0032] A cisteína auxilia na manutenção de níveis saudáveis de glutationa, e desempenha um papel importante no processo de desintoxicação. Faz parte de uma proteína encontrada na pele, nos cabelos e nas unhas e garante a produção adequada de queratina.[0032] Cysteine assists in maintaining healthy glutathione levels, and plays an important role in the detoxification process. It is part of a protein found in the skin, hair and nails and ensures proper keratin production.
[0033] O folato é a forma ativa do ácido fólico, que facilita sua absorção. Ele auxilia na síntese de aminoácidos, e no metabolismo da homocisteína que está relacionada com o surgimento de doenças cardiovasculares como AVC ou infarto cardíaco. Baixos níveis de folato estão associados ao comprometimento cognitivo. A suplementação ideal auxilia com sintomas depressivos e no desempenho imediato da memória.[0033] Folate is the active form of folic acid, which facilitates its absorption. It assists in the synthesis of amino acids, and in the metabolism of homocysteine, which is related to the emergence of cardiovascular diseases such as stroke or heart attack. Low folate levels are associated with cognitive impairment. Optimal supplementation helps with depressive symptoms and immediate memory performance.
[0034] A vitamina B12 auxilia no funcionamento do sistema imune, no metabolismo energético e na formação de células vermelhas do sangue. A deficiência dessa vitamina no organismo pode gerar inicialmente fadiga e falta de energia, tonturas, falhas de memória e falta de atenção e de concentração. Há estudos que indicam a capacidade desse nutriente em reverter quadros depressivos.[0034] Vitamin B12 assists in the functioning of the immune system, energy metabolism and the formation of red blood cells. Deficiency of this vitamin in the body can initially generate fatigue and lack of energy, dizziness, memory failure and lack of attention and concentration. There are studies that indicate the ability of this nutrient to reverse depression.
[0035] O pantotenato de cálcio é uma forma do ácido pantotênico que auxilia no metabolismo energético, ou seja, contribui para o conjunto de reações químicas que que produzem a energia necessária para a realização das funções vitais dos seres vivos. Desempenha papel na redução do cansaço e da fadiga.[0035] Calcium pantothenate is a form of pantothenic acid that assists in energy metabolism, that is, it contributes to the set of chemical reactions that produce the energy needed to carry out the vital functions of living beings. It plays a role in reducing tiredness and fatigue.
[0036] O iodeto de potássio é uma forma altamente biodisponível, fonte de iodo que, por sua vez, auxilia na produção da energia necessária para o desempenho das funções vitais dos seres vivos, ou metabolismo energético. Esse nutriente tem função essencial no cérebro para o desenvolvimento do tecido cerebral. Além disso, também contribui para a manutenção da pele.[0036] Potassium iodide is a highly bioavailable, source of iodine which, in turn, helps in the production of the energy necessary for the performance of vital functions of living beings, or energy metabolism. This nutrient has an essential function in the brain for the development of brain tissue. In addition, it also contributes to the maintenance of the skin.
[0037] A tirosina é um aminoácido precursor de neurotransmissores como a dopamina, que está diretamente relacionada com o controle motor, compensação, prazer e humor.[0037] Tyrosine is an amino acid precursor of neurotransmitters such as dopamine, which is directly related to motor control, compensation, pleasure and mood.
[0038] O triptofano é um aminoácido que auxilia na síntese da serotonina, conhecida por proporcionar a sensação de bem-estar e felicidade, reduzir a ansiedade e regular o sono.[0038] Tryptophan is an amino acid that assists in the synthesis of serotonin, known to provide a feeling of well-being and happiness, reduce anxiety and regulate sleep.
[0039] A vitamina B6 auxilia na formação das células vermelhas do sangue, no funcionamento do sistema imune e no metabolismo energético, proporcionando energia para as funções vitais. Também colabora com o metabolismo de proteínas, carboidratos, gorduras e da homocisteína.[0039] Vitamin B6 assists in the formation of red blood cells, the functioning of the immune system and energy metabolism, providing energy for vital functions. It also collaborates with the metabolism of proteins, carbohydrates, fats and homocysteine.
[0040] O cálcio é um mineral essencial para a formação e manutenção de ossos e dentes, necessário também para o bom funcionamento muscular e neuromuscular e para o metabolismo de energia.[0040] Calcium is an essential mineral for the formation and maintenance of bones and teeth, also necessary for proper muscular and neuromuscular functioning and for energy metabolism.
[0041] O magnésio malato é uma forma com maior biodisponibilidade do magnésio por conter ácido málico. Ele auxilia no equilíbrio de eletrócitos, que mantém os níveis adequados de líquidos para uma boa hidratação, colabora também com o funcionamento muscular e neuromuscular, desempenhando um papel importante na produção de energia para redução de dores musculares. O ácido málico, por sua vez, proporciona recuperação rápida após exercícios, com a capacidade de inverter fraqueza, fadiga e cansaço muscular.[0041] Magnesium malate is a more bioavailable form of magnesium because it contains malic acid. It helps in the balance of electrocytes, which maintains adequate levels of fluids for good hydration, also collaborates with muscle and neuromuscular functioning, playing an important role in the production of energy to reduce muscle pain. Malic acid, in turn, provides rapid recovery after exercise, with the ability to reverse muscle weakness, fatigue and tiredness.
[0042] Os ingredientes do suplemento da presente invenção podem ser formulados em uma composição única ou em uma pluralidade de composições. Além disso, são designados para administração oral, simultânea ou sequencial. Formas farmacêuticas adequadas para administração oral incluem, sem limitação, comprimidos, cápsulas, pastilhas e drágeas.[0042] The supplement ingredients of the present invention may be formulated in a single composition or in a plurality of compositions. In addition, they are designed for oral, simultaneous or sequential administration. Dosage forms suitable for oral administration include, without limitation, tablets, capsules, lozenges and dragees.
[0043] Em uma realização preferencial, os ingredientes são formulados em quatro composições diferentes na forma de cápsula, para serem administradas de forma simultânea ou sequencial. A formulação de cada cápsula age de modo único no organismo, visando:
- a) Relaxar os músculos tensionados e reestabelecer o funcionamento neuromuscular;
- b) Estabelecer os níveis ideias de produção de serotonina para promover a sensação de bem-estar;
- c) Acelerar a eliminação das toxinas do fígado e do sistema nervoso;
- d) Reestabelecer o bom funcionamento neural.
- a) Relax tense muscles and restore neuromuscular functioning;
- b) Establish ideal levels of serotonin production to promote a feeling of well-being;
- c) Accelerate the elimination of toxins from the liver and nervous system;
- d) Reestablish good neural functioning.
[0044] A formulação da presente invenção possui forte ação desintoxicante que promove a eliminação das toxinas acumuladas no organismo, principalmente no fígado e no sistema nervoso, o que evita grande parte do mal-estar do dia seguinte, estimula a produção de serotonina, para proporcionar felicidade e melhora da qualidade do sono e reestabelece o bom funcionamento neuromuscular e neural, evitando os tremores, dores musculares e lentidão no raciocínio.[0044] The formulation of the present invention has a strong detoxifying action that promotes the elimination of toxins accumulated in the body, mainly in the liver and nervous system, which prevents much of the discomfort of the next day, stimulates the production of serotonin, to provide happiness and improve sleep quality and reestablish good neuromuscular and neural functioning, preventing tremors, muscle pain and slow thinking.
[0045] As quatros composições da presente invenção são elencadas abaixo:[0045] The four compositions of the present invention are listed below:
[0046] Composição para relaxar os músculos tensionados e reestabelecer o funcionamento neuromuscular: Cálcio malato 200mg (%VD = 20), magnésio dimalato 200mg (%VD = 77), vitamina E acetato 50mg (%VD = 500), zinco bisglicinato 4mg (%VD = 57), riboflavina cloridrato 2,74mg (%VD = 211), manganês bisglicinato 1,3mg (%VD = 57). Cápsula (gelificante gelatina, corantes D&C YELLOW 310, D&C YELLOW #6 e dióxido de titânio).[0046] Composition to relax tense muscles and restore neuromuscular functioning: Calcium malate 200mg (%DV = 20), magnesium dimalate 200mg (%DV = 77), vitamin E acetate 50mg (%DV = 500), zinc bisglycinate 4mg ( %DV = 57), riboflavin hydrochloride 2.74mg (%DV = 211), manganese bisglycinate 1.3mg (%DV = 57). Capsule (gelatin gelling agent, colors D&C YELLOW 310, D&C YELLOW #6 and titanium dioxide).
[0047] Composição para estabelecer os níveis ideias de produção de serotonina para promover a sensação de bem-estar: Triptofano 300mg, piridoxina cloridrato 98,6mg (%VD = 7584), fenilalanina 80mg. Cápsula (gelificante gelatina, corantes FD&C BLUE #1, FD&C RED #40 e dióxido de titânio).[0047] Composition to establish the ideal levels of serotonin production to promote the feeling of well-being: Tryptophan 300mg, pyridoxine hydrochloride 98.6mg (%DV = 7584), phenylalanine 80mg. Capsule (gelatin gelling agent, FD&C BLUE #1, FD&C RED #40 and titanium dioxide).
[0048] Composição para acelerar a eliminação das toxinas do fígado e do sistema nervoso: Espirulina 200mg, taurina 100mg, cisteína 80mg, bitartarato de colina 70mg (%VD = 13), coenzima Q10 30mg, N-Acetil LCisteína 30mg, ácido linoleico 10mg, glicina 10mg, beta caroteno 2,3mg, selênio 50mcg bisglicinato (%VD = 147). Cápsula (gelificante gelatina, corantes dióxido de titânio, FD&C Blue #1 e FD&C Yellow #5).[0048] Composition to accelerate the elimination of toxins from the liver and nervous system: Spirulina 200mg, Taurine 100mg, Cysteine 80mg, Choline Bitartrate 70mg (%DV = 13), Coenzyme Q10 30mg, N-Acetyl L-Cysteine 30mg, Linoleic Acid 10mg , glycine 10mg, beta carotene 2.3mg, selenium 50mcg bisglycinate (%DV = 147). Capsule (gelatin gelling agent, titanium dioxide dyes, FD&C Blue #1 and FD&C Yellow #5).
[0049] Composição para reestabelecer o bom funcionamento neural: Ácido aspártico 150mg, ácido ascórbico 125mg (%VD = 278), tirosina 100mg, fosfatidilserina 50mg, ácido glutâmico 50mg, cloreto de sódio 14,4mg (%VD = 0,6%), citrato de potássio 13,5mg, pantotenato de cálcio 5,64mg (%VD = 113), iodeto de potássio 900mcg (%VD = 692), metil folato de cálcio 400mcg, cianocobalamina 9,94mcg (%VD = 414). Cápsula (gelificante gelatina, corantes FD&C BLUE #1, D&C RED #33 e dióxido de titânio).[0049] Composition to restore good neural functioning: Aspartic acid 150mg, ascorbic acid 125mg (%DV = 278), tyrosine 100mg, phosphatidylserine 50mg, glutamic acid 50mg, sodium chloride 14.4mg (%DV = 0.6%) , potassium citrate 13.5mg, calcium pantothenate 5.64mg (%DV = 113), potassium iodide 900mcg (%DV = 692), calcium methyl folate 400mcg, cyanocobalamin 9.94mcg (%DV = 414). Capsule (gelatin gelling agent, FD&C BLUE #1, D&C RED #33 and titanium dioxide).
Claims (15)
- a) Cálcio malato 200mg (%VD = 20), magnésio dimalato 200mg (%VD = 77), vitamina E acetato 50mg (%VD = 500), zinco bisglicinato 4mg (%VD = 57), riboflavina cloridrato 2,74mg (%VD = 211), manganês bisglicinato 1,3mg (%VD = 57);
- b) Triptofano 300mg, piridoxina cloridrato 98,6mg (%VD = 7584), fenilalanina 80mg;
- c) Espirulina 200mg, taurina 100mg, cisteína 80mg, bitartarato de colina 70mg (%VD = 13), coenzima Q10 30mg, N-Acetil L-Cisteína 30mg, ácido linoleico 10mg, glicina 10mg, beta caroteno 2,3mg, selênio 50mcg bisglicinato (%VD = 147); e
- d) Ácido aspártico 150mg, ácido ascórbico 125mg (%VD = 278), tirosina 100mg, fosfatidilserina 50mg, ácido glutâmico 50mg, cloreto de sódio 14,4mg (%VD = 0,6%), citrato de potássio 13,5mg, pantotenato de cálcio 5,64mg (%VD = 113), iodeto de potássio 900mcg (%VD = 692), metil folato de cálcio 400mcg, cianocobalamina 9,94mcg (%VD = 414).
- a) Calcium malate 200mg (%DV = 20), magnesium dimalate 200mg (%DV = 77), vitamin E acetate 50mg (%DV = 500), zinc bisglycinate 4mg (%DV = 57), riboflavin hydrochloride 2.74mg (% DV = 211), manganese bisglycinate 1.3mg (%DV = 57);
- b) Tryptophan 300mg, pyridoxine hydrochloride 98.6mg (%DV = 7584), phenylalanine 80mg;
- c) Spirulina 200mg, taurine 100mg, cysteine 80mg, choline bitartrate 70mg (%DV = 13), coenzyme Q10 30mg, N-Acetyl L-Cysteine 30mg, linoleic acid 10mg, glycine 10mg, beta carotene 2.3mg, selenium 50mcg bisglycinate (%DV = 147); and
- d) Aspartic acid 150mg, ascorbic acid 125mg (%DV = 278), tyrosine 100mg, phosphatidylserine 50mg, glutamic acid 50mg, sodium chloride 14.4mg (%DV = 0.6%), potassium citrate 13.5mg, pantothenate calcium 5.64mg (%DV = 113), potassium iodide 900mcg (%DV = 692), calcium methyl folate 400mcg, cyanocobalamin 9.94mcg (%DV = 414).
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BR102020020276-6A BR102020020276A2 (en) | 2020-10-02 | 2020-10-02 | Supplement for physical and mental recovery and kit comprising supplement |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BR102020020276-6A BR102020020276A2 (en) | 2020-10-02 | 2020-10-02 | Supplement for physical and mental recovery and kit comprising supplement |
Publications (1)
Publication Number | Publication Date |
---|---|
BR102020020276A2 true BR102020020276A2 (en) | 2022-04-19 |
Family
ID=81389501
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR102020020276-6A BR102020020276A2 (en) | 2020-10-02 | 2020-10-02 | Supplement for physical and mental recovery and kit comprising supplement |
Country Status (1)
Country | Link |
---|---|
BR (1) | BR102020020276A2 (en) |
-
2020
- 2020-10-02 BR BR102020020276-6A patent/BR102020020276A2/en not_active Application Discontinuation
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10517322B1 (en) | Dietary supplement formulations for promoting sleep | |
US7445807B2 (en) | Agglomerated granular protein-rich nutritional supplement | |
ES2546055T3 (en) | Nutritional supplements for individuals 50 years or older to improve vitality, immunity, eye and bone health | |
WO2008079876A1 (en) | Methods and kits for co-administration of nutritional supplements | |
TW201919602A (en) | Compositions and methods for the treatment of neuronal injury | |
WO2014175773A1 (en) | A formula for restoring normal sleep and biological rhythms | |
JP2008174512A (en) | Composition for ameliorating exhausted feeling at time of rising | |
US8129360B2 (en) | Utilization of phosphatidylserine in the treatment of attention deficit syndrome (ADHS) | |
CA2746902C (en) | A multivitamin/mineral formulation to combat the effects of environmental stress; improve immunity and improve energy while addressing vitamin and mineral deficiencies without the negative side effects of a mega dose nutritional supplement | |
CA2799127A1 (en) | Compositions and methods for treating traumatic brain injury | |
BR102020020276A2 (en) | Supplement for physical and mental recovery and kit comprising supplement | |
RU2698396C1 (en) | Pharmaceutical composition for parenteral drop introduction | |
Babilas | Nutritional diseases | |
EP3527082B1 (en) | Dietary complement composition | |
Van Schoor | Vitamin and mineral supplements | |
Tardner | Best Nootropics For Memory: 11 Top Brain Supplements For Working Memory & Memory Loss | |
US20220313675A1 (en) | Anti-Aging Telomere-Strengthening NAD+ Sirtuin Dietary Supplement Composition | |
BR102020005590A2 (en) | combination of nutrients for supplementation in alzheimer's disease | |
US20220047526A1 (en) | Transdermal patches for use in auriculotherapy | |
Sirius | Drugs-Forum | |
Braverman | The Healing Nutrients Within (Volume 1 of 2)(EasyRead Super Large 18pt Edition) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B03A | Publication of a patent application or of a certificate of addition of invention [chapter 3.1 patent gazette] | ||
B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] |